Healthcare -
Biotechnology - NASDAQ - US
$ 15.88
-19.3 %
$ 1.6 B
Market Cap
-3.49
P/E
BEAM - REVENUE
Revenue BEAM - Beam Therapeutics Inc.
63.5 M
LAST VALUE
2.11%
2 YEAR CAGR
412.30%
5 YEAR CAGR
0.00%
10 YEAR CAGR